Matthew J J Rose-Zerilli
Overview
Explore the profile of Matthew J J Rose-Zerilli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
577
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walker R, Harrington J, Breininger S, Pickering O, Hill S, Sharpe B, et al.
Br J Surg
. 2024 Apr;
111(4).
PMID: 38630793
No abstract available.
2.
Nissanka-Jayasuriya E, Fenton T, Rose-Zerilli M
Br J Oral Maxillofac Surg
. 2024 Jan;
62(2):118-127.
PMID: 38296711
Proliferative verrucous leukoplakia (PVL) is a rare oral potentially malignant disorder characterised by multifocal origin and unpredictable long-term evolution to oral squamous cell carcinoma (OSCC) or oral verrucous carcinoma (OVC)....
3.
Hanley C, Waise S, Ellis M, Lopez M, Pun W, Taylor J, et al.
Nat Commun
. 2023 Jan;
14(1):387.
PMID: 36720863
Fibroblasts are poorly characterised cells that variably impact tumour progression. Here, we use single cell RNA-sequencing, multiplexed immunohistochemistry and digital cytometry (CIBERSORTx) to identify and characterise three major fibroblast subpopulations...
4.
Menassa D, Muntslag T, Martin-Estebane M, Barry-Carroll L, Chapman M, Adorjan I, et al.
Dev Cell
. 2022 Aug;
57(17):2127-2139.e6.
PMID: 35977545
Microglia, the brain's resident macrophages, shape neural development and are key neuroimmune hubs in the pathological signatures of neurodevelopmental disorders. Despite the importance of microglia, their development has not been...
5.
Strefford J, Nowicka M, Hargreaves C, Burton C, Davies A, Ganderton R, et al.
Blood Adv
. 2021 Jul;
5(15):2935-2944.
PMID: 34323957
Single-nucleotide polymorphisms (SNPs) have been shown to influence Fcγ receptor (FcγR) affinity and activity, but their effect on treatment response is unclear. We assessed their importance in the efficacy of...
6.
Izadi F, Sharpe B, Breininger S, Secrier M, Gibson J, Walker R, et al.
Cancers (Basel)
. 2021 Jul;
13(14).
PMID: 34298611
Neoadjuvant therapy followed by surgery is the standard of care for locally advanced esophageal adenocarcinoma (EAC). Unfortunately, response to neoadjuvant chemotherapy (NAC) is poor (20-37%), as is the overall survival...
7.
Harrington J, Esteban L, Butement J, Vallejo A, Lane S, Sheth B, et al.
Lab Chip
. 2021 Jul;
21(17):3378-3386.
PMID: 34240097
The future of single cell diversity screens involves ever-larger sample sizes, dictating the need for higher throughput methods with low analytical noise to accurately describe the nature of the cellular...
8.
Waise S, Parker R, Rose-Zerilli M, Layfield D, Wood O, West J, et al.
Bio Protoc
. 2021 Mar;
9(23):e3440.
PMID: 33654935
Despite their involvement in many physiological and pathological processes, fibroblasts remain a poorly-characterized cell type. Analysis of primary fibroblasts while maintaining their phenotype is challenging: standard methods for fibroblast isolation...
9.
Birts C, Banerjee A, Darley M, Dunlop C, Nelson S, Nijjar S, et al.
Sci Signal
. 2020 May;
13(630).
PMID: 32371497
High rates of glycolysis in cancer cells are a well-established characteristic of many human tumors, providing rapidly proliferating cancer cells with metabolites that can be used as precursors for anabolic...
10.
Blakemore S, Clifford R, Parker H, Antoniou P, Stec-Dziedzic E, Larrayoz M, et al.
Leukemia
. 2020 Feb;
34(7):1760-1774.
PMID: 32015491
Despite advances in chronic lymphocytic leukaemia (CLL) treatment, globally chemotherapy remains a central treatment modality, with chemotherapy trials representing an invaluable resource to explore disease-related/genetic features contributing to long-term outcomes....